Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
Clinical trial NCT01642186 · COMPLETED
Trial details
- NCT number
- NCT01642186
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-12
- Primary completion
- 2021-07-16
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.